Global Infectious Respiratory Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Infectious Respiratory Disease Diagnostics Market is presumed to reach the market size of nearly USD 85.41 BN by 2030 from USD 65.92 BN in 2022 with a CAGR of 2.92% under the study period 2023 - 2030.

Respiratory infectious diseases are caused by viruses, bacteria, or other pathogenic microbes. Microbes that can infect the respiratory system are rapidly spread through saliva & mucus (also referred to as respiratory secretions) when a person sneezes, coughs, talks or laughs. Some common infectious respiratory diseases are influenza, measles, tuberculosis, pertussis, rubella, etc.

MARKET DYNAMICS:

The market for infectious respiratory disease diagnostics is driven by an increasing prevalence of respiratory diseases, increasing use of advanced molecular biology techniques, a rising elderly population, and initiatives taken by the government and low-profile organizations to decrease the risk of infectious diseases. Moreover, increasing usage of self-testing products & point of care products will flourish the market growth. The rise in the development of innovative techniques for meeting the increasing demand for diagnostics & consumables for the diagnosis of infectious diseases is another factor driving the growth of the respiratory disease diagnostics market. The surge in cases of lung diseases, including tuberculosis & pneumonia and other chronic obstructive pulmonary disorders like chronic bronchitis, emphysema, and asthma, will foster market growth. Furthermore, rising demand for diagnostic tests & tools to detect lower respiratory infectious disease will augment the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of infectious respiratory disease diagnostics. The growth and trends of infectious respiratory disease diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the infectious respiratory disease diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
Consumables
Services

By Sample Type

Saliva
Nasopharyngeal Swabs (NPS)
Anterior Nasal Region
Blood
Others

By Application

COVID-19
Influenza
RSV (Respiratory Syncytial Virus)
Tuberculosis
Streptococcus Testing
Other Respiratory Disease Testing

By Technology

Immunoassay
Molecular Diagnostics
Microbiology
Other Technologies

By End-Use

Hospitals
Diagnostic Laboratories
Physician Offices
Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Infectious Respiratory Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the infectious respiratory disease diagnostics market include Abbott, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, Quidel Corporation, QIAGEN, Danaher, Siemens Healthcare GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219207

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Sample Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Technology
- 3.7.5 Market Attractiveness Analysis By End-use
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Historic and Forecast Sales by Regions
6.5 Consumables Historic and Forecast Sales by Regions
6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

7.1 Overview by Sample Type
7.2 Historical and Forecast Data
7.3 Analysis by Sample Type
7.4 Saliva Historic and Forecast Sales by Regions
7.5 Nasopharyngeal Swabs (NPS) Historic and Forecast Sales by Regions
7.6 Anterior Nasal Region Historic and Forecast Sales by Regions
7.7 Blood Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 COVID-19 Historic and Forecast Sales by Regions
8.5 Influenza Historic and Forecast Sales by Regions
8.6 RSV (Respiratory Syncytial Virus) Historic and Forecast Sales by Regions
8.7 Tuberculosis Historic and Forecast Sales by Regions
8.8 Streptococcus Testing Historic and Forecast Sales by Regions
8.9 Other Respiratory Disease Testing Historic and Forecast Sales by Regions

9 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

9.1 Overview by Technology
9.2 Historical and Forecast Data
9.3 Analysis by Technology
9.4 Immunoassay Historic and Forecast Sales by Regions
9.5 Molecular Diagnostics Historic and Forecast Sales by Regions
9.6 Microbiology Historic and Forecast Sales by Regions
9.7 Other technologies Historic and Forecast Sales by Regions

10 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY END-USE

10.1 Overview by End-use
10.2 Historical and Forecast Data
10.3 Analysis by End-use
10.4 Hospitals Historic and Forecast Sales by Regions
10.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
10.6 Physician Offices Historic and Forecast Sales by Regions
10.7 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS COMPANIES

12.1. Infectious Respiratory Disease Diagnostics Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments

13 . COMPANY PROFILES OF INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Abbott
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
13.4. Thermo Fisher Scientific Inc.
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
13.5. Koninklijke Philips N.V.
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
13.6. F. Hoffmann-La Roche Ltd.
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
13.7. bioMerieux SA
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
13.8. BD
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
13.9. Quidel Corporation
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
13.10. QIAGEN
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
13.11. Danaher
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
13.12. Siemens Healthcare GmbH
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies